[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@StreetCred2017 "@LegitInvest @BioValues They never liked Moonlake but have great analysis on all the other HS players in report. $ZURA $IFRX $ABBV $OKRA $AVTX $SNF Seemingly liking Inflarx over others due to value / unique mechanism and it always beat out avacopan - now owned by $AMGN"
X Link @StreetCred2017 2025-10-03T14:12Z XXX followers, XXX engagements

"@Quick2smile @ANKITSH85153215 Interesting and I think Inflarx did same thing w cSCC At end of the day it (C5a antagonist) may wind up being used in combination w some chemo agent. $AMGN $IFRX #PancreaticCancer needs anything that improves XX% survival rates. Compassionate use"
X Link @StreetCred2017 2025-10-06T12:50Z XXX followers, XXX engagements

"@ANKITSH85153215 Friday study showing $AMGN c5aR pathway complement system and soc chemo reduced pancreatic cancer tumor 80%. Big for Avacopan already FDA approved AAV. $IFRX best in c5aR class. #PancreaticCancer very low X yr survival 12%"
X Link @StreetCred2017 2025-10-06T11:09Z XXX followers, XXX engagements

"@Investorclimber @Biotech_AI Gents - any best guess on upside with only X of X showing promise VS both CSU Yes HS -No: or visa versa Guggenheim called 5-10x but seems overly optimistic given need to finance P2b but both wld show pipeline potential. Also partner needed"
X Link @StreetCred2017 2025-10-15T11:40Z XXX followers, XX engagements

"$AMGN Breaking: Avacopan seen blocking pancreatic cancer tumors over XX% when combined with gemcitabine/nab-paclitaxel (standard PDAC chemo) XX% Avacopan motherly only - looks like way bigger market for C5aR inhibitor market than just AAV supporting $4b buyout $CCXI $IFRX still at a whopping $100m In vivo CCX168 monotherapy reduced tumor volume by XX% (p0.01); combining it with gemcitabine/nab-paclitaxel (standard PDAC chemo) and immune checkpoint inhibitors (pembrolizumab/ipilimumab) achieved the strongest effectsup to XX% tumor reduction increased CD8+ T-cell infiltration (p0.01) and"
X Link @StreetCred2017 2025-10-05T23:47Z XXX followers, XXX engagements